北美医用大麻市场预测至 2028 年 - COVID-19 影响和区域分析 - 按产品类型(干燥形式和提取物形式)、应用(疼痛管理、图雷特氏症、阿尔茨海默氏病、偏头痛、抑郁和焦虑、多发性硬化症、癌症等)和分销渠道(零售药房、电子商务等)

BMIRE00028793 | Pages: 127 | Pharmaceuticals | Aug 2023 | Type: Regional | Status: Published

北美医用大麻市场预计将从2022年的71.7017亿美元增长到2028年的207.6041亿美元。预计2022年至2028年的复合年增长率为19.4%。   ; 

医用大麻产品审批的增加推动北美医用大麻市场的增长

< p>大麻的药用潜力吸引了各种研究人员和公司在医疗应用中使用大麻。例如,四氢大麻酚 (THC) 主要用于生产医药产品。美国食品和药物管理局 (FDA) 已批准基于 THC 的药品,例如 Cesamet,其活性成分为 naboline,是一种具有类似 THC 结构的合成衍生产品。 Cesamet 用于治疗接受化疗的患者的恶心。当其他药物无法控制恶心和呕吐时,通常会开出 Cesamet。 FDA 还批准 Marinol 和 Syndros 在美国用于治疗用途。 Marinol 和 Syndros 含有活性成分屈大麻酚——一种合成的 9-THC,被认为是大麻的精神活性成分。 Marinol 和 Syndros 药物用于刺激消耗综合症患者的食欲,消耗综合症是艾滋病的适应症之一。同样,各种基于大麻的产品已获得批准或正在进行临床试验。例如,nabiximols (Sativex) 是在加拿大批准商业化的药物。 Nabiximols 是一种大麻提取物,用于治疗与多发性硬化症相关的痉挛和神经性疼痛。它由 THC 和其他大麻二酚 (CBD) 组合配制而成。 2020年2月,加拿大公司CanaQuest Medical Corp向加拿大卫生部申请批准Mentabinol的生产和商业化。 Mentabinol 是一种基于 THC 的产品,其批准申请已根据《大麻法》提交。 FDA 对上述大麻产品的批准增加正在推动医用大麻市场的发展。

北美医用大麻市场概览

北美医用大麻市场分为美国、加拿大和墨西哥。据估计,医用大麻市场在美国占有最大份额。医用大麻市场的增长可归因于探索创新治疗应用的研究和合作不断增加、人们对医用大麻的认识不断提高以及该地区主要参与者的存在。此外,该地区不断增长的老龄化人口也将有利于市场的增长。

到2028年北美医用大麻市场收入和预测(美国)百万美元)

北美医用大麻市场细分

北美医用大麻市场分为产品类型、应用、分销渠道和国家。

根据产品类型,北美医用大麻市场分为干燥形式和提取物形式。 2022 年,提取物形式在北美医用大麻市场中占据较大份额。

根据应用,北美医用大麻市场分为疼痛管理、妥瑞氏症、阿尔茨海默病、偏头痛、抑郁症和焦虑症、多发性硬化症、癌症等。 2022年,疼痛管理细分市场在北美医用大麻市场中占据最大份额。

根据分销渠道,北美医用大麻市场分为零售药店、零售药店、零售药店和电子药店。 -商业及其他。 2022年,零售药房领域在北美医用大麻市场中占据最大份额。

按国家划分,北美医用大麻市场分为美国、加拿大、和墨西哥。 2022 年,美国将主导北美医用大麻市场。

Aphria, Inc.; CanaQuest 医疗公司; Canopy Growth 公司;翡翠健康治疗公司; GW 制药公司;马里坎公司; Organigram 控股公司;帕纳夏制药工业有限公司;菲娜控股公司;和 VIVO Cannabis Inc 是北美医用大麻市场的领先公司。   

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Medical Marijuana Market – by Product

1.3.2        North America Medical Marijuana Market – by Application

1.3.3        North America Medical Marijuana Market – by Distribution Channel

1.3.4        North America Medical Marijuana Market – by Country

2.           North America Medical Marijuana Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Medical Marijuana Market – Market Landscape

4.1         Overview

4.2         North America – PEST Analysis

4.3         Expert Opinion

5.           North America Medical Marijuana Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Approvals of Medical Marijuana Products

5.1.2        Rising Acceptance of Medicinal Use of Marijuana in America

5.2         Market Restraints

5.2.1        Illegal Use of Cannabis as Street Drug and Misconceptions Regarding Marijuana

5.3         Market Opportunities

5.3.1        Increase in Job Opportunities in Marijuana Industry

5.4         Future Trends

5.4.1        Widespread Distribution of Medical Marijuana

5.5         Impact Analysis

6.           Medical Marijuana Market – North America Analysis

6.1         North America Medical Marijuana Market Revenue Forecast and Analysis

7.           North America Medical Marijuana Market Revenue and Forecast To 2028– by Product

7.1         Overview

7.2         North America Medical Marijuana Market Revenue Share, by Product (2021 and 2028)

7.3         Dried Form

7.3.1        Overview

7.3.2        Dried Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Extract Form

7.4.1        Overview

7.4.2        Extract Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.           North America Medical Marijuana Market Analysis – by Application

8.1         Overview

8.2         North America Medical Marijuana Market Revenue Share, by Application (2021 and 2028)

8.3         Pain Management

8.3.1        Overview

8.3.2        Pain Management: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Tourette’s

8.4.1        Overview

8.4.2        Tourette’s: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Alzheimer’s Disease

8.5.1        Overview

8.5.2        Alzheimer’s Disease: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Migraines

8.6.1        Overview

8.6.2        Migraines: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.7         Depression and Anxiety

8.7.1        Overview

8.7.2        Depression and Anxiety: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.8         Multiple Sclerosis

8.8.1        Overview

8.8.2        Multiple Sclerosis: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.9         Cancer

8.9.1        Overview

8.9.2        Cancer: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.10      Others

8.10.1     Overview

8.10.2     Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

9.           North America Medical Marijuana Market – by Distribution Channel

9.1         Overview

9.2         North America Medical Marijuana Market, by Distribution Channel (2021 and 2028)

9.3         Retail Pharmacy

9.3.1        Overview

9.3.2        Retail Pharmacy: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

9.4         E-Commerce

9.4.1        Overview

9.4.2        E-commerce: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Others

9.5.1        Overview

9.5.2        Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.        North America Medical Marijuana Market Revenue and Forecast to 2028 – Country Analysis

10.1      Overview

10.1.1     North America Medical Marijuana Market, by Country, 2021 & 2028 (%)

10.1.1.1       US: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       US: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.2       US: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       US: Medical Marijuana Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.4       US: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2       Canada: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Canada: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.2       Canada: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       Canada: Medical Marijuana Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4       Canada: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3       Mexico: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Mexico: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.2       Mexico: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       Mexico: Medical Marijuana Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4       Mexico: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

11.        North America Medical Marijuana Market – Industry Landscape

11.1      Overview

11.2      Growth Strategies in the North America Medical Marijuana Market (%)

11.3      Organic Developments

11.3.1     Overview

11.4      Inorganic Developments

11.4.1     Overview

12.        Company Profiles

12.1      VIVO Cannabis Inc

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Panaxia Pharmaceutical Industries Ltd.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Phoena Holdings Inc.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Emerald Health Therapeutics Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      MARICANN INC.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Aphria, Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Canopy Growth Corporation

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      CanaQuest Medical Corporation

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      GW Pharmaceuticals

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Organigram Holdings Inc.

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms for North America Medical Marijuana Market

 

LIST OF TABLES

Table 1.             US: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2.             US: Medical Marijuana Market, by Application – Revenue and Forecast to 2028 (US$ Million).

Table 3.             US: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Canada: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Canada: Medical Marijuana Market, by Application – Revenue and Forecast to 2028 (US$ Million).

Table 6.             Canada: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Mexico: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Mexico: Medical Marijuana Market, by Application – Revenue and Forecast to 2028 (US$ Million).

Table 9.             Mexico: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Organic Developments in the Medical Marijuana Market

Table 11.          Inorganic Developments in the Medical Marijuana Market

Table 12.          Glossary of Terms for North America Medical Marijuana Market

 

 

LIST OF FIGURES

Figure 1.           North America Medical Marijuana Market Segmentation

Figure 2.           North America Medical Marijuana Market, By Country

Figure 3.           North America Medical Marijuana Market Overview

Figure 4.           Extract Form Held Largest Share of Product Segment in Medical Marijuana Market

Figure 5.           US to Show Remarkable Growth During Forecast Period

Figure 6.           North America PEST Analysis

Figure 7.           North America Medical Marijuana Market– Revenue Forecast and Analysis – 2020- 2028

Figure 8.           North America Medical Marijuana Market Revenue Share, by Product (2021 and 2028)

Figure 9.           Dried Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.        Extract Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        North America Medical Marijuana Market Revenue Share, by Application (2021 and 2028)

Figure 12.        Pain Management: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Tourette’s: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Alzheimer’s Disease: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Migraines: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Depression and Anxiety: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Multiple Sclerosis: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Cancer: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        North America Medical Marijuana Market, by Distribution Channel (2021 and 2028)

Figure 21.        Retail Pharmacy: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        E-commerce: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        North America Medical Marijuana Market, by Key Country – Revenue (2021) (US$ Million)

Figure 25.        North America Medical Marijuana Market, by Country, 2021 & 2028 (%)

Figure 26.        US: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Canada: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Mexico: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Growth Strategies in the North America Medical Marijuana Market (%) 

  1. Aphria, Inc.
  2. CanaQuest Medical Corporation
  3. Canopy Growth Corporation
  4. Emerald Health Therapeutics Inc.
  5. GW Pharmaceuticals
  6. MARICANN INC.
  7. Organigram Holdings Inc.
  8. Panaxia Pharmaceutical Industries Ltd.
  9. Phoena Holdings Inc.
  10. VIVO Cannabis Inc
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America medical marijuana market .
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in North America medical marijuana market , thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$2400
Site License
$4000
$3200
Enterprise License
$5000
$4000